- Exchange: Toronto
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharma
Resverlogix Corp+ Add to Watchlist
RVX:CN1.6300 CAD 0.0800 5.16%
As of 15:59:55 ET on 03/27/2015.
Company Profile for Resverlogix Corp (RVX)
Resverlogix Corp. is a biotechnology company focused on developing therapies for unmet medical needs. The Company concentrates on cardiovascular disease, cancer, and fibrotic conditions.
Key Executives for Resverlogix Corp (RVX)
|Donald J McCaffreyPresident/CEO/Secretary||Aaron Bradley Cann "Brad"Chief Financial Officer|
|Norman WongChief Scientific Officer||Kenneth LebiodaSenior VP:Bus & Corporate Dev|
|Jan O JohanssonSenior VP:Medical Affairs|